Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

1.

The Premonitory Phase of Migraine - What Can We Learn From It?

Maniyar FH, Sprenger T, Monteith T, Schankin CJ, Goadsby PJ.

Headache. 2015 Apr 28. doi: 10.1111/head.12572. [Epub ahead of print]

PMID:
25919990
2.

HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer.

Styczen H, Nagelmeier I, Beissbarth T, Nietert M, Homayounfar K, Sprenger T, Boczek U, Stanek K, Kitz J, Wolff HA, Ghadimi BM, Middel P, Liersch T, Rüschoff J, Conradi LC.

Oncotarget. 2015 Apr 13. [Epub ahead of print]

3.

Consistent reduction in the annualized rate of brain volume loss across phase 3 core and extension trials of fingolimod in relapsing multiple sclerosis.

Radue EW, Sprenger T, Chin P, Meier DP, Sfikas N, Barkhof F.

Mult Scler Relat Disord. 2014 Nov;3(6):750-1. doi: 10.1016/j.msard.2014.09.181. Epub 2014 Nov 21.

PMID:
25891586
4.

MRI characteristics of periaqueductal lesions in multiple sclerosis.

Papadopoulou A, Naegelin Y, Weier K, Amann M, Hirsch J, von Felten S, Yaldizli O, Sprenger T, Radue EW, Kappos L, Gass A.

Mult Scler Relat Disord. 2014 Jul;3(4):542-51. doi: 10.1016/j.msard.2014.01.001. Epub 2014 Jan 18.

PMID:
25877067
5.

Comprehensive lymph node morphometry in rectal cancer using acetone compression.

Scheel AH, Reineke RA, Sprenger T, Lokka S, Kitz J, Ghadimi BM, Rüschoff J, Liersch T, Middel P.

J Clin Pathol. 2015 Mar 16. pii: jclinpath-2014-202555. doi: 10.1136/jclinpath-2014-202555. [Epub ahead of print]

PMID:
25779094
6.

Safety of teriflunomide for the management of relapsing-remitting multiple sclerosis.

Papadopoulou A, Kappos L, Sprenger T.

Expert Opin Drug Saf. 2015 May;14(5):749-59. doi: 10.1517/14740338.2015.1014795. Epub 2015 Feb 17.

PMID:
25687236
7.

Genetic associations with brain cortical thickness in multiple sclerosis.

Matsushita T, Madireddy L, Sprenger T, Khankhanian P, Magon S, Naegelin Y, Caverzasi E, Lindberg RL, Kappos L, Hauser SL, Oksenberg JR, Henry R, Pelletier D, Baranzini SE.

Genes Brain Behav. 2015 Feb;14(2):217-27. doi: 10.1111/gbb.12190. Epub 2015 Mar 5.

PMID:
25684059
8.

Fingolimod effect on brain volume loss independently contributes to its effect on disability.

Sormani M, De Stefano N, Francis G, Sprenger T, Chin P, Radue E, Kappos L.

Mult Scler. 2015 Feb 6. pii: 1352458515569099. [Epub ahead of print]

PMID:
25662353
9.

Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis.

Radue EW, Barkhof F, Kappos L, Sprenger T, Häring DA, de Vera A, von Rosenstiel P, Bright JR, Francis G, Cohen JA.

Neurology. 2015 Feb 24;84(8):784-93. doi: 10.1212/WNL.0000000000001281. Epub 2015 Jan 28.

10.

Subcortical brain segmentation of two dimensional T1-weighted data sets with FMRIB's Integrated Registration and Segmentation Tool (FIRST).

Amann M, Andělová M, Pfister A, Mueller-Lenke N, Traud S, Reinhardt J, Magon S, Bendfeldt K, Kappos L, Radue EW, Stippich C, Sprenger T.

Neuroimage Clin. 2014 Nov 18;7:43-52. doi: 10.1016/j.nicl.2014.11.010. eCollection 2015.

11.

The Role of the Cerebellum in Multiple Sclerosis.

Weier K, Banwell B, Cerasa A, Collins DL, Dogonowski AM, Lassmann H, Quattrone A, Sahraian MA, Siebner HR, Sprenger T.

Cerebellum. 2015 Jan 13. [Epub ahead of print]

PMID:
25578034
12.

No abnormalities of intrinsic brain connectivity in the interictal phase of migraine with aura.

Hougaard A, Amin FM, Magon S, Sprenger T, Rostrup E, Ashina M.

Eur J Neurol. 2015 Apr;22(4):702-e46. doi: 10.1111/ene.12636. Epub 2015 Jan 9.

PMID:
25573335
13.

Comparison between balanced steady-state free precession and standard spoiled gradient echo magnetization transfer ratio imaging in multiple sclerosis: methodical and clinical considerations.

Amann M, Sprenger T, Naegelin Y, Reinhardt J, Kuster P, Hirsch JG, Kappos L, Radue EW, Stippich C, Bieri O.

Neuroimage. 2015 Mar;108:87-94. doi: 10.1016/j.neuroimage.2014.12.045. Epub 2014 Dec 20.

PMID:
25536494
14.

The role of cerebellar abnormalities in neuromyelitis optica - a comparison with multiple sclerosis and healthy controls.

Weier K, Eshaghi A, Magon S, Andelova M, Radue EW, Kappos L, Azimi AR, Sahraian MA, Sprenger T.

Mult Scler. 2014 Dec 5. pii: 1352458514554051. [Epub ahead of print]

PMID:
25480863
15.

The origin of nausea in migraine-a PET study.

Maniyar FH, Sprenger T, Schankin C, Goadsby PJ.

J Headache Pain. 2014 Dec 3;15:84. doi: 10.1186/1129-2377-15-84.

16.

Reduced volume of the nucleus accumbens in heroin addiction.

Seifert CL, Magon S, Sprenger T, Lang UE, Huber CG, Denier N, Vogel M, Schmidt A, Radue EW, Borgwardt S, Walter M.

Eur Arch Psychiatry Clin Neurosci. 2014 Dec 3. [Epub ahead of print]

PMID:
25467383
17.

Long-term remission of prostate cancer with extensive bone metastases upon immuno- and virotherapy: A case report.

Schirrmacher V, Bihari AS, Stücker W, Sprenger T.

Oncol Lett. 2014 Dec;8(6):2403-2406. Epub 2014 Oct 6.

18.

White matter lesion filling improves the accuracy of cortical thickness measurements in multiple sclerosis patients: a longitudinal study.

Magon S, Gaetano L, Chakravarty MM, Lerch JP, Naegelin Y, Stippich C, Kappos L, Radue EW, Sprenger T.

BMC Neurosci. 2014 Sep 8;15:106. doi: 10.1186/1471-2202-15-106.

19.

Clinical characteristics of pain in patients with pituitary adenomas.

Dimopoulou C, Athanasoulia AP, Hanisch E, Held S, Sprenger T, Toelle TR, Roemmler-Zehrer J, Schopohl J, Stalla GK, Sievers C.

Eur J Endocrinol. 2014 Nov;171(5):581-91. doi: 10.1530/EJE-14-0375. Epub 2014 Aug 12.

PMID:
25117460
20.

Intrathecal gadolinium for magnetic resonance myelography in spontaneous intracranial hypotension: valuable but may be risky--reply.

Papadopoulou A, Ahlhelm FJ, Sprenger T.

JAMA Neurol. 2014 Jun;71(6):802-3. doi: 10.1001/jamaneurol.2014.577. No abstract available.

PMID:
24911131
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk